MEDVi Quad vs Shed

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

MEDVi Quad vs Shed: Overview

Choosing between MEDVi Quad and Shed for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.

MEDVi Quad offers both semaglutide and tirzepatide at $114/month with a rating of 6.5/10. Shed also provides both semaglutide and tirzepatide at $159/month with a 8.1/10 rating.

With only a $45/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$45/mo
Rating Difference
1.6
Winner
Shed
Best For
Quality

MEDVi Quad

View full MEDVi Quad review →
Rating
6.5/10
Monthly Price
$114Cheaper
Medications
sildenafiltadalafilbremelanotide (PT-141)L-citrulline

Pros

  • $114/month, reduced from a stated $179, and the price is all-in: doctor consultation, free rush shipping and 24/7 medical support are included with no separate consultation fee (checked July 28, 2026)
  • Cancel anytime, and the page states you are not charged if you do not qualify
  • All four active ingredients are named openly - PT-141 (bremelanotide), L-citrulline, sildenafil and tadalafil - rather than hidden behind a proprietary blend name
  • Sublingual delivery is a real advantage over tablets: it bypasses first-pass metabolism, so onset is faster and a heavy meal does not blunt absorption the way it can with oral sildenafil
  • Backed by a substantial independent review record - roughly 14,000 Trustpilot reviews at 4.4, with 99% of negative reviews answered
  • A published phone number, email address and physical address, which many competitors in this category omit entirely

Cons

  • 'Peak rigidity guaranteed' appears directly in the product copy. No prescription medication can guarantee an outcome, and this is the most explicit outcome promise we have seen across every provider reviewed on this site
  • The formula stacks two PDE5 inhibitors - sildenafil and tadalafil - and then adds L-citrulline, a nitric oxide precursor. All three act on the same nitric oxide and cGMP pathway, so the blood-pressure-lowering effect compounds three ways rather than one
  • PT-141 adds a fourth agent that independently causes low blood pressure, nausea and flushing. Four actives, four routes to hypotension, and no discussion anywhere on the page of the combined risk
  • Bremelanotide's only FDA approval is as Vyleesi, an autoinjector for premenopausal women with hypoactive sexual desire disorder. Prescribing it to men in a compounded sublingual liquid is off-label and a different route of administration
  • The word FDA does not appear on the page at all. The product is compounded, and the page never states the consequence - that compounded preparations are not reviewed or approved by the FDA for safety, efficacy or quality
  • 'The world's first 4-in-1 formula' and 'hospital-grade power' are unverifiable marketing superlatives attached to a prescription product
  • The advertised Trustpilot score covers MEDVi's business as a whole rather than this specific product
  • The published address is a suite at a Delaware registered-agent building, not a clinical facility
  • Anyone taking nitrates or riociguat must not use this product. The PT-141 component also interacts with 5-HT3 anti-emetics such as ondansetron, and stacking two PDE5 inhibitors makes the nitrate contraindication more dangerous, not less
Choose MEDVi Quad

Shed

View full Shed review →
Rating
8.1/10Better
Monthly Price
$159
Medications
semaglutidetirzepatide

Pros

  • Compounded semaglutide advertised from $159/mo and compounded tirzepatide from $239/mo, alongside brand-name Wegovy, Zepbound and the new Foundayo pill (checked July 26, 2026)
  • Three delivery formats: weekly injections, daily sublingual liquid drops and daily lozenges, so needle-free options are genuinely available
  • A 120-day weight loss guarantee that is actually written into the terms with defined conditions, rather than an unexplained banner claim
  • The arbitration clause and class action waiver can be opted out of within 30 days of accepting the terms
  • Buy-now-pay-later refunds are handled explicitly: Shed transmits refunds to Affirm, Klarna or Afterpay within three business days, and the terms state each lender's refund window
  • Non-GLP-1 options too - metformin, naltrexone, topiramate, MIC + B12 - so a provider has alternatives if a GLP-1 is not appropriate
  • Health coaching and a member success manager are part of the program, not an upsell
  • Members enrolled under a previous guarantee are grandfathered rather than moved to worse terms

Cons

  • The '120-Day Weight Loss Guarantee' is far more demanding than the asterisk suggests. To qualify you must log at least two weigh-ins a month (eight over the period), complete at least 50% of daily app check-ins - 60 days out of 120 - and submit every provider follow-up form on time. Miss the check-in quota and the guarantee lapses
  • The guarantee only pays out if you fail to lose 5% of your baseline body weight, so modest results still disqualify you from a refund
  • Trustpilot showed 1.8 out of 5, albeit from just 22 reviews - a small but uniformly poor public signal
  • Oral formats are not available in Alaska, Alabama, Arkansas, Connecticut, Indiana, Kentucky, Louisiana, Michigan, Minnesota, North Carolina, New Jersey, South Carolina, Virginia, Vermont, Wisconsin or West Virginia
  • 'As low as $159' is a floor price; the site does not publish the plan ladder or say what commitment that rate requires
  • Shed's own product menu misspells its second GLP-1 as 'Compounded Trizepatide', which is not reassuring on a prescription page
  • The compounded products are not FDA-approved, and the '15%' and '20%' body-weight figures on the landing page come from trials of the branded drugs
  • Disputes go to binding arbitration unless you actively opt out in the first 30 days
Choose Shed

Feature-by-feature comparison

FeatureMEDVi QuadShed
Monthly Price$114$159
Rating6.5/108.1/10
Medicationssildenafil, tadalafil, bremelanotide (PT-141), L-citrullinesemaglutide, tirzepatide
Insurance AcceptedNoNo
Support Hours24/7 medical support advertisedNot published
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedFree rush shipping included in the monthly priceNot published
Mobile AppNoAvailable
Dedicated CoachNot includedIncluded
Follow-up Frequency24/7 medical support advertised; follow-up cadence not publishedDaily app check-ins expected under the guarantee, plus provider follow-up forms
Money-back GuaranteeNo charge if you do not qualify; no refund policy published for dispensed medication120-day guarantee, but only if you complete 60 daily app check-ins, 8 weigh-ins and every provider form, and still fail to lose 5% of baseline body weight
Cancellation PolicyCancel anytimeSubscription based; refunds are governed by the 120-day guarantee conditions, with BNPL refunds transmitted within 3 business days

Which should you choose?

Choose MEDVi Quad if you:

  • Want to save $45/month with a more affordable option
  • Want more medication options to choose from
  • Value: $114/month, reduced from a stated $179, and the price is all-in: doctor consultation, free rush shipping and 24/7 medical support are included with no separate consultation fee (checked july 28, 2026)

Choose Shed if you:

  • Prefer a higher-rated service (8.1/10 vs 6.5/10)
  • Want personalized coaching support included
  • Value: compounded semaglutide advertised from $159/mo and compounded tirzepatide from $239/mo, alongside brand-name wegovy, zepbound and the new foundayo pill (checked july 26, 2026)

Website previews

MEDVi Quad

MEDVi Quad website

Shed

Shed website

Our recommendation

Shed comes out ahead with a higher rating of 8.1/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with Shed

Compare other providers

Compare GLP-1 Brands